Key result
RotaTeq vaccination resulted in 3 cases of acute gastroenteritis in healthy infants who shed a stable G1P[8] human-bovine double reassortant rotavirus in their stools.
Population
3 healthy infants with acute gastroenteritis
Design
Case_series
Authors
Loading...
Rare symptomatic shedding post-RotaTeq warrants clinical awareness; hypothesis-generating for reassortant transmissibility and surveillance.
RotaTeq vaccination can result in the shedding of a human-bovine double reassortant rotavirus, which may cause diarrheal symptoms and potentially be transmitted to contacts.
Hemming et al. (2012) studied this question. RotaTeq vaccination resulted in 3 cases of acute gastroenteritis in healthy infants who shed a stable G1P[8] human-bovine double reassortant rotavirus in their stools.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: